使用标准delta-9-tetrahydrocannabinol (THC) 单位估计大麻使用障碍风险值
Rachel Lees Thorne1, Will Lawn2, Kat Petrilli1,3
1Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, UK.
Addiction (Abingdon, England)
|January 12, 2026
概括
降低大麻使用障碍 (CUD) 风险需要了解安全的delta-9-tetrahydrocannabinol (THC) 极限. 这项研究确定了成人和青少年的每周THC单位值,以帮助制定更安全的大麻使用指南.
科学领域:
- 成研究研究成研究
- 大麻研究研究大麻研究.
- 公共卫生 公共卫生
背景情况:
- 大麻使用障碍 (CUD) 构成了严重的公共卫生负担.
- 制定大麻消费低风险指南对于减少危害至关重要.
- 为了确定更安全的使用水平,需要为delta-9-tetrahydrocannabinol (THC) 摄入量设定值.
研究的目的:
- 根据每周的THC消费量来确定CUD的风险值.
- 为了区分任何CUD与中度/严重CUD的风险水平.
- 为THC摄入提供特定年龄 (成人和青少年) 的风险值.
主要方法:
- 纵向观察性研究 (CannTeen) 在12个月内进行5次评估.
- 使用验证的时间线随访量化每周标准THC单位 (1单位=5毫克THC).
- 利用接收器操作特征 (ROC) 曲线分析,以确定CUD诊断的最佳风险值 (DSM-5标准).
主要成果:
- 每周的THC单位消费精确地区分了没有CUD和任何CUD (AUC>0.70).
- 任何CUD的最佳风险值为成年人每周8.26单位,青少年每周6.04单位.
- 中度/重度CUD的最佳风险值为成年人每周13.44单位,青少年每周6.45单位.
结论:
- 每周THC消费水平有效预测不同严重程度和年龄组的CUD风险.
- 确定特定的每周THC单位值可以为制定更安全的大麻使用准则提供信息.
- 降低每周THC单位消费量可能会减少CUD的发生率和严重程度.
相关概念视频
Substance Use Disorders Affecting Sleep
394
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
394
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
658
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
658


